Search

Your search keyword '"Loukianos S. Rallidis"' showing total 242 results

Search Constraints

Start Over You searched for: Author "Loukianos S. Rallidis" Remove constraint Author: "Loukianos S. Rallidis"
242 results on '"Loukianos S. Rallidis"'

Search Results

1. Lipoprotein (a) and cerebrovascular disease

2. Lipid Accumulation Product Is Predictive of Cardiovascular Hospitalizations among Patients with Stable Ischemic Heart Disease: Long-Term Follow-Up of the LAERTES Study

3. Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis

4. Differential Expression of Circulating Damage-Associated Molecular Patterns in Patients with Coronary Artery Ectasia

5. Rationale and design of the Hellenic Registry of Clinical events and Adherence to Lipid LowerINg therapy In aCUte coronary Syndrome (CALLINICUS-Hellas Registry)

6. Emergent Inflammatory Markers and Echocardiographic Indices in Patients with Bronchial Asthma

7. Stress echocardiography: differences between practices in Greece. A survey of the Echocardiology Working Group of the Hellenic Society of Cardiology

8. PCSK9 inhibitors in clinical practice: Novel directions and new experiences

9. A practical algorithm for the management of patients with statin-associated muscle symptoms

10. Lipoprotein(a): Its Association with Calcific Aortic Valve Stenosis, the Emerging RNA-Related Treatments and the Hope for a New Era in 'Treating' Aortic Valve Calcification

12. Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse

13. Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits

14. The Role of Exercise Doppler Echocardiography to Unmask Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis and Equivocal Baseline Echocardiographic Values for Pulmonary Hypertension

17. Myocardial infarction due to left main coronary artery total occlusion: A unique electrocardiographic presentation

18. Emergent Inflammatory Markers and Echocardiographic Indices in Patients with Bronchial Asthma

20. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

21. Differential prognostic value of resistin for cardiac death in patients with coronary artery disease according to the presence of metabolic syndrome

22. Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH

23. Homozygosity of the TT methylenetetrahydrofolate reductase C677T genotype is an independent long-term predictor of cardiac death in patients with premature myocardial infarction

24. Lipoprotein apheresis: a Hellenic consensus on its clinical use

25. The value of physical signs in identifying patients with familial hypercholesterolemia in the era of genetic testing

26. Nutrition, dietary habits, and weight management to prevent and treat patients with peripheral artery disease

27. The association of sodium intake with successful aging, in 3,349 middle-aged and older adults: Results from the ATTICA and MEDIS cross-sectional epidemiological studies

28. PCSK9 inhibitors in clinical practice: Novel directions and new experiences

29. The association of animal and plant protein with successful ageing: a combined analysis of MEDIS and ATTICA epidemiological studies

30. Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity

32. Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits

33. Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardioraphy Is Non-Diagnostic for Pulmonary Hypertension

34. LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

35. The Role of Exercise Doppler Echocardiography to Unmask Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis and Equivocal Baseline Echocardiographic Values for Pulmonary Hypertension

36. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants

38. Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors

40. Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden

41. Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection

42. Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse

43. The association between homocysteine levels, Mediterranean diet and cardiovascular disease: a case-control study

44. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants

45. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

46. Lipid profile and body mass index in patients with familial hypercholesterolemia: An analysis from the HELLAS-FH registry

47. Prevalence of non-coronary heart disease in patients with familial hypercholesterolemia: An analysis from the HELLAS-FH

48. Abstract 14969: A Four Week Exercise Intervention in a Cohort of Young Army Recruits is Associated With Anti-inflammatory and Pro-antioxidant Responses

49. The new LDL-C target <55 mg/dL is achieved by less than 40% of very high risk patients with familial hypercholesterolaemia despite receiving PCSK9 inhibitors: real world data

50. Hyperhomocysteinemia as the only risk factor in a young man presenting with ST-elevation myocardial infarction

Catalog

Books, media, physical & digital resources